Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19065567 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated SU5416 in Treating Children With Recurrent or Progressive Brain Tumors
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: semaxanib

Indicates status has not been verified in more than two years